FI883177A - Anvaendning av ett medium med hoeg affinitet foer tumoerer. - Google Patents

Anvaendning av ett medium med hoeg affinitet foer tumoerer. Download PDF

Info

Publication number
FI883177A
FI883177A FI883177A FI883177A FI883177A FI 883177 A FI883177 A FI 883177A FI 883177 A FI883177 A FI 883177A FI 883177 A FI883177 A FI 883177A FI 883177 A FI883177 A FI 883177A
Authority
FI
Finland
Prior art keywords
tumoerer
affinitet
anvaendning
foer
medium med
Prior art date
Application number
FI883177A
Other languages
English (en)
Other versions
FI883177A0 (fi
Inventor
Sirkka-Liisa Karonen
Jan Lindgren
Hannu Aronen
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of FI883177A0 publication Critical patent/FI883177A0/fi
Publication of FI883177A publication Critical patent/FI883177A/fi
Priority to FI942151A priority Critical patent/FI942151A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Motorcycle And Bicycle Frame (AREA)
FI883177A 1987-07-08 1988-07-04 Anvaendning av ett medium med hoeg affinitet foer tumoerer. FI883177A (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI942151A FI942151A (fi) 1987-07-08 1994-05-10 Välitysaineen käyttö, jolla on suuri affiniteetti kasvaimiin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873722522 DE3722522A1 (de) 1987-07-08 1987-07-08 Verwendung eines vehikels mit hoher affinitaet zu tumoren

Publications (2)

Publication Number Publication Date
FI883177A0 FI883177A0 (fi) 1988-07-04
FI883177A true FI883177A (fi) 1989-01-09

Family

ID=6331118

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883177A FI883177A (fi) 1987-07-08 1988-07-04 Anvaendning av ett medium med hoeg affinitet foer tumoerer.

Country Status (13)

Country Link
EP (1) EP0298436B1 (fi)
JP (1) JPH01125331A (fi)
KR (1) KR890001508A (fi)
AT (1) ATE81473T1 (fi)
AU (1) AU623080B2 (fi)
DE (2) DE3722522A1 (fi)
DK (1) DK167561B1 (fi)
ES (1) ES2046244T3 (fi)
FI (1) FI883177A (fi)
GR (1) GR3006404T3 (fi)
NO (1) NO883040L (fi)
NZ (1) NZ225350A (fi)
ZA (1) ZA884870B (fi)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
US4663146A (en) * 1983-07-29 1987-05-05 Codon Genetic Engineering Laboratories Methods and compositions for the diagnosis of bloodclots using plasminogen activator

Also Published As

Publication number Publication date
EP0298436B1 (de) 1992-10-14
JPH01125331A (ja) 1989-05-17
DK167561B1 (da) 1993-11-22
NZ225350A (en) 1991-07-26
EP0298436A3 (en) 1990-01-17
DK377588A (da) 1989-01-09
DE3875290D1 (de) 1992-11-19
ES2046244T3 (es) 1994-02-01
ATE81473T1 (de) 1992-10-15
DK377588D0 (da) 1988-07-07
DE3722522A1 (de) 1989-01-19
KR890001508A (ko) 1989-03-27
AU1889588A (en) 1989-01-12
FI883177A0 (fi) 1988-07-04
ZA884870B (en) 1989-04-26
GR3006404T3 (fi) 1993-06-21
NO883040L (no) 1989-01-09
NO883040D0 (no) 1988-07-07
AU623080B2 (en) 1992-05-07
EP0298436A2 (de) 1989-01-11

Similar Documents

Publication Publication Date Title
DK0566601T3 (da) Ekkokontrastmiddel
SE8005256L (sv) Framstellningsforfarande
NO175158C (no) Fremstilling av human livmorsvevplasminogenaktivator med rekombinant-DNA
ATE61000T1 (de) Verfahren zur erhoehung der zielspezifizitaet in antikoerperbestimmungen und zur raeumung von nichtzielspezifischen diagnostischen und therapeutischen faktoren.
NO170886C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive benzotiofener
DE3688721T2 (de) Verwendung von Porphyrinderivaten bei der Entdeckung und Behandlung von Tumoren.
SE8404283L (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
DE69024382D1 (de) Fledermausspeichel-Plasminogenaktivator vPA-alpha 1
FI101597B1 (fi) Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa
NO164353C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridopyrimidiner.
FI883177A (fi) Anvaendning av ett medium med hoeg affinitet foer tumoerer.
IT1147788B (it) Procedimento per la preparazione di attivatori di plasminogeni utili come agenti terapeutici e diagnostici
DE3764697D1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
FI844645A0 (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
ATE79255T1 (de) Wirkstoffe zur verhuetung von tumormetastasen.
ES2040765T3 (es) Procedimiento para preparar un agente para el tratamiento de enfermedades angiogenas o tumores.
NO901995L (no) Ny variant av human vevtypeplasminogenaktivator.
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
DE69113437D1 (de) Therapeutische Mittel für diabetisches Gangrän.
IT8048370A0 (it) Agente per la diagnosi di tumori eprocedimento per il suo trattamento
UA13670A1 (uk) Засіб передпосівhої обробки hасіhhя
AU3430189A (en) Compounds for diagnosis and/or therapy of tumours

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH